首页 › 小细胞肺癌 › 密歇根州 › Grand Rapids
Grand Rapids MI 小细胞肺癌临床试验
9项针对 小细胞肺癌的研究正在 Grand Rapids及周边约 30 英里内的站点招募参与者。打开研究详情可查看入选标准及联系研究团队的方式。
官方研究文本(英文)
正在为研究招募参与者?将此页面置顶展示 — $99 / 30天 →
AVA6103 in Subjects With Locally Advanced or Metastatic Selected Solid Tumors
招募中1 期
- START Midwest, Grand Rapids
177Lu-BetaBart in Patients With Relapsed/Refractory, Locally Advanced Inoperable, or Metastatic Solid Tumors
招募中1/2 期
- BAMF Health, Grand Rapids
A Study to Evaluate Adverse Events and Change in Disease Activity of Intravenous ABBV-706 Versus Standard of Care in Adult Participants With Relapsed/Refractory Small Cell Lung Cancer
招募中3 期
- Cancer And Hematology Centers Of Western Michigan - Grand Rapids /ID# 279955, Grand Rapids
A Study of ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid Tumors
招募中1/2 期
- START Midwest, Grand Rapids
Phase 3 Trial of Tarlatamab (SC vs IV) in Extensive-Stage Small Cell Lung Cancer After Platinum Based First-line Chemotherapy (ES-SCLC)
招募中3 期
- Cancer and Hematology Centers of Western Michigan, Grand Rapids
A Study of MGC026 in Participants With Advanced Solid Tumors
招募中1 期
- START Midwest, Grand Rapids
A Study of SGN-CEACAM5C in Adults With Advanced Solid Tumors
招募中1 期
- START Midwest, Grand Rapids
A Study of IDE849 in Patients With DLL3 Expressing Tumors Including Small Cell Lung Cancer
招募中1/2 期
- START Midwest, Grand Rapids
- The Cancer and Hematology Centers, Grand Rapids
Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors
招募中1/2 期
- START Midwest, Grand Rapids
其他城市的 小细胞肺癌试验
- Houston, TX26 项研究
- Arlington, VA23 项研究
- New York City, NY22 项研究
- Boston, MA21 项研究
- Los Angeles, CA20 项研究
- Nashville, TN20 项研究
- Orlando, FL15 项研究
- Dallas, TX13 项研究
- Cleveland, OH13 项研究
- Chicago, IL13 项研究
- St. Louis, MO13 项研究
- Detroit, MI12 项研究
Grand Rapids的其他研究
- 非小细胞肺癌44 项研究
- 结直肠癌40 项研究
- 癌症(所有类型)28 项研究
- 乳腺癌26 项研究
- 卵巢癌24 项研究
- 转移性癌症22 项研究
- 前列腺癌19 项研究
- 子宫内膜癌18 项研究
- 胃癌18 项研究
- 胰腺癌18 项研究
- 黑色素瘤17 项研究
- 头颈鳞状细胞癌15 项研究
数据来自 ClinicalTrials.gov,检索日期:2026年10月6日。每项研究自行设定入选标准,由研究团队决定谁能参与。